Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
Al-Tourah
Abdulwahab J
AJ
Division of Medical Oncology, British Columbia Cancer Agency, Vancouver General Hospital, British Columbia Cancer Agency, and the University of British Columbia, Vancouver, BC, Canada.
Tsang
Peter W K
PW
Skinnider
Brian F
BF
Hoskins
Paul J
PJ
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004921:Erythropoietin / Q000097:blood; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000209:etiology* / Q000628:therapy; D018962:Phlebotomy; D011086:Polycythemia / Q000097:blood / Q000209:etiology* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D004921:Erythropoietin; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone